Jason Gardner
2019 - Dianthus Therapeutics
In 2019, Jason Gardner earned a total compensation of $1.7M as President and Chief Executive Officer at Dianthus Therapeutics, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $231,750 |
|---|---|
| Option Awards | $903,764 |
| Salary | $515,000 |
| Other | $487 |
| Total | $1,651,001 |
Gardner received $903.8K in option awards, accounting for 55% of the total pay in 2019.
Gardner also received $231.8K in non-equity incentive plan, $515K in salary and $487 in other compensation.
Rankings
In 2019, Jason Gardner's compensation ranked 6,846th out of 13,971 executives tracked by ExecPay. In other words, Gardner earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,846 out of 13,971 | 51st |
Division Manufacturing | 2,616 out of 5,701 | 54th |
Major group Chemicals And Allied Products | 956 out of 2,200 | 57th |
Industry group Drugs | 807 out of 1,886 | 57th |
Industry Pharmaceutical Preparations | 592 out of 1,398 | 58th |
Source: SEC filing on April 21, 2021.
Gardner's colleagues
We found one more compensation record of an executive who worked with Jason Gardner at Dianthus Therapeutics in 2019.
2019
John Davis
Dianthus Therapeutics
Chief Medical Officer
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019